zolpidem has been researched along with Electrocardiogram QT Prolonged in 5 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zolpidem, a short-acting hypnotic drug prescribed to treat insomnia, has been clinically associated with acquired long QT syndrome (LQTS) and torsade de pointes (TdP) tachyarrhythmia." | 7.79 | Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. ( Becker, R; Deschenes, I; Ficker, E; Jehle, J; Katus, HA; Kisselbach, J; Schmidt, C; Schweizer, PA; Staudacher, I; Thomas, D; Wan, X; Wiedmann, F, 2013) |
| "Zolpidem, a short-acting hypnotic drug prescribed to treat insomnia, has been clinically associated with acquired long QT syndrome (LQTS) and torsade de pointes (TdP) tachyarrhythmia." | 3.79 | Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. ( Becker, R; Deschenes, I; Ficker, E; Jehle, J; Katus, HA; Kisselbach, J; Schmidt, C; Schweizer, PA; Staudacher, I; Thomas, D; Wan, X; Wiedmann, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ | 1 |
| Jeong, WJ | 1 |
| Kim, KJ | 1 |
| Kim, SC | 1 |
| Kim, DW | 1 |
| Chang, HJ | 1 |
| Kang, CS | 1 |
| Oh, SK | 1 |
| Cho, SU | 1 |
| Min, JH | 1 |
| Cho, YC | 1 |
| Park, JS | 1 |
| Ryu, S | 1 |
| You, YH | 1 |
| Lee, JW | 1 |
| Kim, MS | 1 |
| Suarez, L | 1 |
| Kolla, BP | 1 |
| Hall-Flavin, D | 1 |
| Mansukhani, MP | 1 |
| Jehle, J | 1 |
| Ficker, E | 1 |
| Wan, X | 1 |
| Deschenes, I | 1 |
| Kisselbach, J | 1 |
| Wiedmann, F | 1 |
| Staudacher, I | 1 |
| Schmidt, C | 1 |
| Schweizer, PA | 1 |
| Becker, R | 1 |
| Katus, HA | 1 |
| Thomas, D | 1 |
| Letsas, KP | 1 |
| Filippatos, GS | 1 |
| Kounas, SP | 1 |
| Efremidis, M | 1 |
| Sideris, A | 1 |
| Kardaras, F | 1 |
| Somberg, J | 1 |
| Molnar, J | 1 |
5 other studies available for zolpidem and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Serial plasma and urine measurements of a patient with acute intoxication of zolpidem and flunitrazepam resulting in QT prolongation and ventricular tachycardia.
Topics: Aged; Electrocardiography; Female; Flunitrazepam; Humans; Long QT Syndrome; Poisoning; Tachycardia, | 2020 |
QTc Prolongation Secondary to Zolpidem Use.
Topics: Aged; Female; Humans; Long QT Syndrome; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance | 2020 |
Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
Topics: Action Potentials; Animals; Cells, Cultured; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; | 2013 |
QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Electric Countershock; Female; Heart Co | 2006 |
Letter from Konstantinos P. Letsas et al. - invited editorial comment.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Humans; Hypnotics and Sedatives; Long QT Synd | 2006 |